Getwell Oncology

Gurugram, India Founded: 1985 • Age: 41 yrs
Manufacturing and supplying anti-cancer drugs with a focus on oncology pharmaceuticals in India.

About Getwell Oncology

Getwell Oncology is a Healthcare company based in Gurugram (India) founded in 1985. Manufacturing and supplying anti-cancer drugs with a focus on oncology pharmaceuticals in India. Getwell Oncology has raised $1.81 million across 2 funding rounds. The company has 111 employees. Its Indian entity Getwell Pharma India Private Limited reported revenue of β‚Ή56.34 Cr. Getwell Oncology offers products and services including Liquid Vials and Lyophilized Vials. Its focus areas include Pharmaceuticals, Oncology, Drug Manufacturing and Research and Development.

Company details

Getwell Oncology has been operational since 1985, where high-quality pharmaceutical products are delivered through state-of-the-art manufacturing and research facilities. Oncology medicines are produced with a commitment to global standards, emphasizing innovation in drug development and patient support programs. Collaborations for CSR initiatives, such as cancer awareness and health camps, are undertaken to enhance community well-being. The companys efforts in research and development ensure that effective treatments are provided, aiming to improve cancer care outcomes worldwide while prioritizing safety and efficacy in all processes.

Key Metrics
  • Annual Revenue
    ₹56.34 Cr

    FY 2025 · +76% YoY

  • Net Profit
    ₹2.04 Cr

    FY 2025 · 4% margin

  • EBITDA
    ₹9.98 Cr

    FY 2025 · 18% margin

  • Total Equity Funding
    $1.81M (USD)

    in 2 rounds

  • Latest Funding Round
    $1.38M (USD), Unspecified

    Feb 2025

  • Employee Count
    111

Products & Services of Getwell Oncology

Getwell Oncology offers a comprehensive portfolio of products and services, including Liquid Vials and Lyophilized Vials.

Liquid Vials
Oncology Drugs

Anti-cancer drugs in liquid form are produced for treatment purposes.

Lyophilized Vials
Oncology Drugs

Freeze-dried formulations of anti-cancer drugs are manufactured for enhanced stability and efficacy.

Apps and channels of Getwell Oncology

its YouTube channel Getwell Oncology has 6 subscribers.

Getwell Oncology
YouTube 6 subscribers
Open channel

Funding Insights of Getwell Oncology

Getwell Oncology has successfully raised a total of $1.81M across 2 strategic funding rounds. The most recent funding activity was a Unspecified round of $1.38 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.81M
  • Total Rounds 2
  • Last Round Unspecified β€” $1.38M
  • First Round $425,739

    (Mar 2023)

All 2 funding rounds of Getwell Oncology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2025$1.38MUnspecified––
–
Mar 2023$425,739Seed––
–

Board of directors of Getwell Pharma India Private Limited (Getwell Oncology)

Getwell Pharma India Private Limited is the primary company behind Getwell Oncology. The board of Getwell Pharma India Private Limited currently have 4 directors; the longest-serving is Manas Tandon, appointed in 2017. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Manas Tandon
DIN 02869499
Director19 Jan 20179 yrs 9 moGetwell Pharma India Private Limited
Mini Tandon
DIN 02869806
Director19 Jan 20179 yrs 9 moGetwell Pharma India Private Limited
Prerna Tandon
DIN 06605029
Director15 Apr 20224 yrs 7 moGetwell Pharma India Private Limited
Rakesh Dwivedi
DIN 06605034
Director16 Oct 20233 yrsGetwell Pharma India Private Limited

People of Getwell Oncology

3 people are tracked at Getwell Oncology (1 in leadership, 2 in team); the tracked headcount is 111.

NameRoleGroup
Maanas Tandon
CEOLeadership
Rajeev Kesharwani
Human Resources ManagerTeam
Vaasvi Mehrotra
Executive (project Management & Drug Regulatory Affairs)Team
Premium access

Complete people profiles for Getwell Oncology

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Getwell Oncology

Figures of Getwell Pharma India Private Limited, the primary company behind Getwell Oncology, for FY 2025. Revenue was ₹56.34 Cr (+76% year on year). Net profit was ₹2.04 Cr (4% margin). EBITDA was ₹9.98 Cr (18% margin).

  • ₹56.34 CrRevenue · FY 2025 · +76% YoY
  • ₹2.04 CrNet profit · 4% margin
  • ₹9.98 CrEBITDA · 18% margin
  • ₹32.75 CrPaid-up capital
  • 111Employees (provident fund records)

Balance sheet, profit and loss, cash flow and ratios of Getwell Pharma India Private Limited are on its company page.

Premium access

Detailed financial statements for Getwell Oncology

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Getwell Oncology

3 dated milestones of Getwell Oncology across 40 years, from founding to its latest funding, stage changes and deals.

  1. Founded Getwell Oncology is founded.
  2. Funding First funding round of $426K.
  3. Funding Latest funding round, Unspecified, of $1.4M.

Web traffic of Getwell Oncology

The website of Getwell Oncology (getwelloncology.com) receives about 1.3K visits a month.

  • Monthly visits
    1.3K

    ▲ 4.2% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Getwell Oncology

Getwell Oncology was founded in 1985 and raised its 1st funding round 38 years after it was founded.

Getwell Oncology is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.

Getwell Oncology is a funded company, having raised a total of $1.81M across 2 funding rounds to date. The company's 1st funding round was a Seed of $425.74K, raised on Mar 2023.

Getwell Oncology has 111 employees.

The primary company behind Getwell Oncology, Getwell Pharma India Private Limited, reported revenue of β‚Ή56.34 Cr for FY 2025, up 76% year on year.

Getwell Oncology has been operational since 1985, where high-quality pharmaceutical products are delivered through state-of-the-art manufacturing and research facilities. Oncology medicines are produced with a commitment to global standards, emphasizing innovation in drug development and patient support programs. Collaborations for CSR initiatives, such as cancer awareness and health camps, are undertaken to enhance community well-being. The companys efforts in research and development ensure that effective treatments are provided, aiming to improve cancer care outcomes worldwide while prioritizing safety and efficacy in all processes.

Getwell Oncology offers Liquid Vials and Lyophilized Vials.

Getwell Oncology operates through Getwell Pharma India Private Limited.

The legal entities of Getwell Oncology currently have 5 directors, including Sonia Ahuja, Manas Tandon, Mini Tandon and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available